Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine-propofol versus propofol infusion for brain relaxation in supratentorial tumor surgery
IRCT20230204057318N5Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Nov 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketamine, propofol and fentanyl in supratentorial neoplasm (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Brain relaxation. Started Nov 2024; status: completed.
02
Drugs
ketaminepropofolfentanyl
03
Conditions
supratentorial neoplasm
Beyond the preview
Go deeper on IRCT20230204057318N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230204057318N5.